Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ITRACONAZOLE USP, with a corresponding US DMF Number 17739.
Remarkably, this DMF maintains an Active status since its submission on October 08, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 27, 2013, and payment made on February 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II